- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.70 BnMarket Estimate, 2026
$0.74 BnMarket Forecast, 2034
$1.16 BnCAGR, 2026–2034
5.77%Executive Summary: Europe Oxygen Therapy Market
- Market Scope: Comprehensive European respiratory care assessment covering product types (oxygen source equipment like concentrators and cylinders, delivery interfaces like nasal cannulas and masks), clinical indications (COPD, asthma, sleep apnea, cystic fibrosis), end-users (home healthcare, hospitals), and sub-regional country markets.
- Market Valuation: Valued at USD 0.70 billion (2025), estimated at USD 0.74 billion (2026), and projected to reach USD 1.16 billion by 2034, registering a solid CAGR of 5.77% (2026–2034).
- Primary Growth Drivers: High prevalence of chronic respiratory disorders (such as COPD across France, the UK, and Germany), aging demographic trends across the EU, and a systemic healthcare shift toward home-based ambulatory respiratory management.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Product Type | Oxygen source equipment (capturing the largest share via stationary and fixed units for baseline clinical/home support) | Portable oxygen concentrators (POCs) & dynamic delivery devices (driven by demand for patient mobility and travel) |
| By Application | Chronic Obstructive Pulmonary Disease - COPD (dominating due to high adult prevalence rates across Western Europe) | Obstructive sleep apnea & respiratory distress syndromes (reflecting rising clinical diagnoses and out-of-hospital care) |
| By End-User | Home healthcare settings (holding the majority share as European health systems prioritize community-based chronic care) | Hospitals and specialized ambulatory clinics (growing steadily with acute care modernization and emergency respiratory interventions) |
| By Region / Country | Western Europe / Major economies like Germany, France, and the UK (leading in cumulative market revenue) | Nordic and Southern European markets (experiencing rapid adoption driven by aging cohorts and supportive reimbursement) |
Major Market Players & Market Structure
Market Structure: Highly competitive, regulated medical device market dominated by international healthcare conglomerates and respiratory specialists focusing on energy-efficient concentrator tech, compact lithium battery systems, and smart telehealth connectivity.
Key Companies: Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company, Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries, Inc., Allied Healthcare Products Inc., Respan Products Inc., and others.
Europe Oxygen Therapy Market Size
The europe oxygen therapy market size was valued at USD 0.70 billion in 2025 and is anticipated to reach USD 0.74 billion in 2026 from USD 1.16 billion by 2034, growing at a CAGR of 5.77% during the forecast period from 2026 to 2034.
Oxygen Therapy devices are useful, especially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their bodies. The advantages of oxygen therapy include increased mental stamina, reduced risk of heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part of the management of numerous diseases. Furthermore, oxygen therapy applies to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance life expectancy and quality.
In Europe, the prevalence of COPD varies markedly across countries. For example, the Ministère de la Santé et des Solidaritiés estimates that between 6% and 8% of the adult population in France suffers from COPD. Interestingly, the Netherlands displays a 2% prevalence rate as evaluated by the National Institute for Public Health and the Environment. Generally, these devices are used to treat patients who are no longer able to receive adequate oxygen volumes through the breathing of natural air and require higher concentrations of oxygen.
A significant increase is expected in the number of patients on oxygen therapy as the population ages. As members of the 50 to 75 age demographics, who were often smokers in their youth, develop emphysema and related conditions. It is estimated that over 85% of the patients on oxygen therapy are once smokers.
Regionally, Europe has the second-highest revenue in the oxygen therapy devices market and is expected to grow further in the coming years. Favorable government policies and initiatives, such as the Europe Committee for Hyperbaric Medicine (ECHM, involve promoting awareness about the treatment and thereby promoting the growth of the oxygen therapy devices market.
KEY MARKET PLAYERS
Companies leading the market include
- Chart Industries Inc.
- Invacare Corporation
- Becton, Dickinson and Company
- Smiths Medical
- Teleflex Incorporated
- Inogen, Inc.
- DeVilbiss Healthcare
- Essex Industries, Inc.
- Allied Healthcare Products Inc.
- Respan Products Inc.
MARKET SEGMENTATION
This research report on the European Oxygen Therapy Market has been segmented & sub-segmented into the following categories:
By Product Type
- Oxygen Source Equipment
- Oxygen Concentrators
- Fixed Oxygen Concentrators
- Portable Oxygen Concentrators
- Liquid Oxygen Devices
- Oxygen Cylinders
- Oxygen Concentrators
- Oxygen Delivery Devices
- Oxygen Masks
- Nasal Cannulas
- Venturi Masks
- Non-Rebreather Masks
- Bag Valve Masks
- Other Devices
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
By End-user
- Home Healthcare
- Hospitals
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe